Keith Gottesdiener
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Keith Gottesdiener
Earlier roles on record: CEO and Board Member at Prime Medicine, Inc. (PRME) until May 18, 2025. Prime Medicine, Inc. reported in an 8-K filed May 19, 2025 that Keith Gottesdiener resigned as member of the Board of Directors, effective May 18, 2025. Prime Medicine, Inc. reported in an 8-K filed May 19, 2025 that Keith Gottesdiener resigned as President, Chief Executive Officer and principal executive officer, effective May 18, 2025. The proxy statement of Prime Medicine, Inc. reports total compensation of $2,207,770 for Keith Gottesdiener in fiscal 2025, including a base salary of $259,568. Disclosed compensation is on record for 5 fiscal years.
“On May 19, 2025, Prime Medicine, Inc. (the “Company”) announced that Keith Gottesdiener, M.D. had resigned as President, Chief Executive Officer and principal executive officer of the Company, and as a member of the Board of Directors of the Company (the “Board”), as well as from all other officer and director positions he held with the Company and any of its subsidiaries, in each case effective as of the end of day on May 18, 2025 (the “Resignation”).”
“On May 19, 2025, Prime Medicine, Inc. (the “Company”) announced that Keith Gottesdiener, M.D. had resigned as President, Chief Executive Officer and principal executive officer of the Company, and as a member of the Board of Directors of the Company (the “Board”), as well as from all other officer and director positions he held with the Company and any of its subsidiaries, in each case effective as of the end of day on May 18, 2025 (the “Resignation”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-05-18
-
Start not stated–2025-05-18
-
Start not stated–2025-05-18
-
Start not stated–2025-05-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Prime Medicine, Inc. (PRME) | Former Chief Executive Officer | $259,568 | $2,207,770 |
| 2024 | Prime Medicine, Inc. (PRME) | Former Chief Executive Officer | $652,792 | $2,245,617 |
| 2023 | Prime Medicine, Inc. (PRME) | President & Chief Executive Officer | $625,000 | $5,403,071 |
| 2022 | Prime Medicine, Inc. (PRME) | President & Chief Executive Officer | $542,340 | $924,044 |
| 2021 | Prime Medicine, Inc. (PRME) | President & Chief Executive Officer | $524,000 | $2,939,433 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.